Cargando…
Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2(S310F) mutated extramammary Paget’s disease
Metastatic extramammary Paget’s disease is a rare adenocarcinoma with poor prognosis. Several reports of human epidermal growth factor receptor 2 alterations point to its pathogenic role in the disease. However, the occurrence of treatment resistance to anti-HER2 therapy demand the need for further...
Autores principales: | Nordmann, Thierry M., Messerli-Odermatt, Olivia, Meier, Larissa, Micaletto, Sara, Coppetti, Thomas, Nägeli, Mirjam, Kamarachev, Jivko, Kudura, Ken, Freiberger, Sandra N., Rordorf, Tamara, Mangana, Joanna, Braun, Ralph, Dummer, Reinhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877105/ https://www.ncbi.nlm.nih.gov/pubmed/31803359 http://dx.doi.org/10.18632/oncotarget.27272 |
Ejemplares similares
-
Frequent FOXA1-Activating Mutations in Extramammary Paget’s Disease
por: Takeichi, Takuya, et al.
Publicado: (2020) -
Extramammary Paget’s disease
por: Vasquez, Andres, et al.
Publicado: (2016) -
Extramammary Perianal Paget's Disease
por: Al Hallak, M.N., et al.
Publicado: (2009) -
Mammary and extramammary Paget's disease()
por: Lopes, Lauro Lourival, et al.
Publicado: (2015) -
Extramammary Paget's Disease in Two Brothers
por: Zhang, Xiaoting, et al.
Publicado: (2015)